Medindia

X

Elsevier Collaborates With ACCSES by Providing DirectCourse Curricula to Disability Service Providers

Tuesday, November 15, 2016 General News J E 4
Advertisement

PHILADELPHIA, November 15, 2016 /PRNewswire/ --

DirectCourse training helps DSPs improve the lives of people with disabilities, meet compliance requirements, and reduce liability 

Elsevier, a world-leading provider of scientific, technical and medical information products and services, will offer Elsevier's DirectCourse eLearning curricula to the more than 1,200 organizations in the ACCSES network that provide exceptional services to people with disabilities across the United States. 

"ACCSES is excited about extending this added member benefit to our network of providers who strive every day to ensure people with the most significant disabilities have the greatest amount of options and opportunities to live work and play," said ACCSES President & CEO Terry R. Farmer. "We look forward to our partnership with DirectCourse and its team to continue to advance the services and supports our members provide."

DirectCourse curricula are research driven, built around a nationally recognized set of competencies from the Centers for Medicare and Medicaid Services (CMS), are evidence-based and peer reviewed to ensure that support professionals can provide the best guidance in helping people with disabilities reach their full potential through self-determination.

"Elsevier and its university research content partners, led by University of Minnesota Research and Training Center, provide the education and training necessary to enable direct support and peer support professionals help persons with disabilities live fuller and richer lives," said Barbara Cullen, Vice President, Strategy and Product Development, Elsevier. "We look forward to offering this unique educational benefit to ACCSES members."

DirectCourse, a collaboration between Elsevier and the University of Minnesota's Research and Training Center on Community Living and three other recognized research universities, is an online training curriculum designed to empower support and care professionals in helping persons with disabilities lead meaningful lives within their communities. For additional information on DirectCourse program offerings, visit directcourseonline.com.

---

About ACCSES 

ACCSES is an elite network of more than 1,200 disability service providers promoting and enhancing community-based solutions that maximize employment and independent living opportunities for people with disabilities. ACCSES provides a voice for these individuals at the highest levels of government. Its advocacy efforts resonate throughout the halls of Congress, executive agencies, and the White House. http://www.accses.org

About Elsevier 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey - and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. http://www.elsevier.com

Media contact Christopher Capot Director, Corporate Relations, Elsevier +1 917 704 5174 c.capot@elsevier.com

SOURCE Elsevier

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Boston Scientific Acquires Resectr™ Tissue Resecti...
S
CutisPharma Unveils New Drug Research And Developm...